| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Institute of Allergy and Infectious Diseases (NIAID) |
| Information provided by: | National Institute of Allergy and Infectious Diseases (NIAID) |
| ClinicalTrials.gov Identifier: | NCT00001070 |
Purpose
This is a study to evaluate the tolerance and antiviral effect of oral vitamin C in HIV-infected.
| Condition | Intervention |
|
HIV Infections |
Drug: Oral Vitamin C |
| MedlinePlus related topics: | AIDS |
| Drug Information available for: | Ascorbic acid |
| Study Type: | Interventional |
| Study Design: | Treatment, Dose Comparison, Efficacy Study |
| Official Title: | A Dose Escalation Study to Evaluate Tolerance and Antiviral Effect of Oral Vitamin C in Two Groups of HIV-Infected Adults |
Eligibility
| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Contacts and Locations More Information
| Study ID Numbers: | DATRI 017 |
| First Received: | November 2, 1999 |
| Last Updated: | June 23, 2005 |
| ClinicalTrials.gov Identifier: | NCT00001070 |
| Health Authority: | United States: Federal Government |
|
|
|
|
|
